Virax Biolabs Group Limited (VRAX)

NASDAQ: VRAX · Real-Time Price · USD

0.2145

+0.0075 (3.62%)

At close: Mar 6, 2026, 4:00 PM EST

0.2157

+0.0012 (0.56%)

After-hours: Mar 6, 2026, 6:52 PM EST

Virax Biolabs Group Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 6, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	2	5	2	11	-	-
Market Cap Growth	-79.85%	192.29%	-84.34%	-	-	-
Enterprise Value	-1	-2	-4	6	-	-
Last Close Price	0.21	1.14	0.72	6.95	-	-
PS Ratio	533.26	781.84	10.83	1262.87	-	-
PB Ratio	0.26	0.91	0.33	1.21	-	-
P/TBV Ratio	0.30	0.88	0.32	1.21	-	-
EV/Sales Ratio	-	-	-	701.38	-	-
Debt / Equity Ratio	0.11	0.13	0.04	0.02	-	-0.21
Net Debt / Equity Ratio	-0.57	-0.66	-0.67	-1.04	0.02	-0.19
Net Debt / EBITDA Ratio	0.52	0.61	0.57	-	-	-
Net Debt / FCF Ratio	0.49	0.70	0.48	2.21	0.03	-0.27
Asset Turnover	0	0.00	0.02	0.00	-	3.98
Inventory Turnover	0.27	0.32	1.01	0.44	-	-
Quick Ratio	9.89	6.47	23.01	10.35	0.02	0.02
Current Ratio	11.35	7.27	25.94	10.61	0.04	0.05
Return on Equity (ROE)	-83.82%	-114.47%	-95.98%	-141.63%	-	-
Return on Assets (ROA)	-48.40%	-64.68%	-49.90%	-72.67%	-2453.52%	-1294.67%
Return on Capital Employed (ROCE)	-109.70%	-107.10%	-114.90%	-64.40%	144.90%	77.50%
Earnings Yield	-354.42%	-122.45%	-397.61%	-50.48%	-	-
FCF Yield	-370.69%	-104.40%	-425.13%	-38.66%	-	-
Buyback Yield / Dilution	-70.75%	-85.92%	-88.75%	-11.15%	-297.67%	-130.43%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q